CVA Family Office’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85K Buy
35
+7
+25% +$554 ﹤0.01% 1444
2026
Q1
$2.04K Buy
+28
New +$2.18K ﹤0.01% 1521
2025
Q2
– Sell
-5
Closed -$474 – 1365
2025
Q1
$474 Buy
+5
New +$529 ﹤0.01% 1302

Other funds holding IOSP

CVA Family Office's IOSP Position: Q2 2026 in Review

CVA Family Office increased its Innospec (IOSP) stake by 25% in Q2 2026, buying an estimated $554 and bringing the position to 35 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1444.

CVA Family Office first reported a position in IOSP in Q1 2025 and has held it in 3 quarters since. 281 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

  • CVA Family Office held 35 shares of Innospec worth $2.85K as of Q2 2026.
  • CVA Family Office bought 7 Innospec shares in Q2 2026, an estimated $554.
  • Innospec made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1444 holding.
  • CVA Family Office first reported a position in Innospec in Q1 2025 and has held it in 3 quarters since.
  • 281 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.